2023 - Research.com Biology and Biochemistry in United States Leader Award
2012 - Robert J. and Claire Pasarow Foundation Medical Research Award
2011 - Distinguished Scientist Award, American Heart Association
2006 - Fellow of the American Academy of Arts and Sciences
2001 - Member of the National Academy of Medicine (NAM)
2000 - Member of the National Academy of Sciences
1998 - Fellow of the American Association for the Advancement of Science (AAAS)
1994 - Metlife Foundation Award for Medical Research in Alzheimer's Disease
Member of the Association of American Physicians
His primary areas of study are Apolipoprotein E, Biochemistry, Endocrinology, Internal medicine and Apolipoprotein B. Robert W. Mahley has researched Apolipoprotein E in several fields, including LDL receptor, Very low-density lipoprotein, Lipoprotein and Molecular biology. In general Endocrinology, his work in Plasma lipoprotein, Type 2 diabetes and Insulin resistance is often linked to Enolase linking many areas of study.
His work in the fields of Hypertriglyceridemia overlaps with other areas such as Fetus. His Apolipoprotein B research incorporates elements of Genetic disorder, Neurodegeneration, Apolipoprotein C2, Lipid metabolism and Gene isoform. His Cholesterol study combines topics from a wide range of disciplines, such as Genetics and Disease.
Robert W. Mahley mainly focuses on Apolipoprotein E, Internal medicine, Endocrinology, Biochemistry and Apolipoprotein B. His studies deal with areas such as Receptor, LDL receptor, Lipoprotein and Low-density lipoprotein as well as Apolipoprotein E. His work carried out in the field of Lipoprotein brings together such families of science as Lipoprotein lipase and Ligand.
His studies in Internal medicine integrate themes in fields like Turkish population, Genetically modified mouse and Cardiology. His Biochemistry study which covers Cell biology that intersects with Neurite and Cytoskeleton. His study looks at the relationship between Apolipoprotein B and fields such as Molecular biology, as well as how they intersect with chemical problems.
His primary areas of investigation include Apolipoprotein E, Internal medicine, Endocrinology, Apolipoprotein B and Cell biology. His specific area of interest is Apolipoprotein E, where Robert W. Mahley studies Apolipoproteins E. His work carried out in the field of Internal medicine brings together such families of science as Single-nucleotide polymorphism and Cardiology.
His study ties his expertise on Genetics together with the subject of Endocrinology. His studies in Apolipoprotein B integrate themes in fields like Receptor, Small molecule, Neuropathology, Lipoprotein and Gene isoform. His research integrates issues of Alzheimer's disease, Apolipoprotein e4, Amyloid precursor protein and Protein structure, Biochemistry in his study of Cell biology.
The scientist’s investigation covers issues in Apolipoprotein E, Apolipoprotein B, Neurodegeneration, Genetics and Endocrinology. His Apolipoprotein E research incorporates elements of Biochemistry, Cholesterol and Cell biology. His Apolipoprotein B research is multidisciplinary, relying on both Neuropathology, Receptor, Genotype and Gene isoform.
His biological study spans a wide range of topics, including In situ hybridization, Microglia, Transfection, Molecular biology and Gene knockin. His work on Genome-wide association study, Genomics and Denisovan is typically connected to European community as part of general Genetics study, connecting several disciplines of science. His work in Endocrinology is not limited to one particular discipline; it also encompasses Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
Robert W. Mahley.
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Josée Dupuis;Josée Dupuis;Claudia Langenberg;Inga Prokopenko;Richa Saxena;Richa Saxena.
Nature Genetics (2010)
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (vol 42, pg 105, 2010)
J Dupuis;C Langenberg;I Prokopenko;R Saxena.
Nature Genetics (2010)
Apolipoprotein E: far more than a lipid transport protein.
Robert W. Mahley;Stanley C. Rall.
Annual Review of Genomics and Human Genetics (2000)
A genome-wide association search for type 2 diabetes genes in African Americans.
N D Palmer;C W McDonough;P J Hicks;B H Roh.
PLOS ONE (2012)
Plasma lipoproteins: apolipoprotein structure and function.
R W Mahley;T L Innerarity;S C Rall;K H Weisgraber.
Journal of Lipid Research (1984)
Ancient human genomes suggest three ancestral populations for present-day Europeans
Iosif Lazaridis;Iosif Lazaridis;Nick Patterson;Alissa Mittnik;Gabriel Renaud.
Apolipoprotein E4: A Causative Factor and Therapeutic Target in Neuropathology, Including Alzheimer's Disease
Robert W. Mahley;Karl H. Weisgraber;Yadong Huang.
Proceedings of the National Academy of Sciences of the United States of America (2006)
The Simons Genome Diversity Project: 300 genomes from 142 diverse populations
Swapan Mallick;Swapan Mallick;Swapan Mallick;Heng Li;Mark Lipson;Iain Mathieson.
Lipoprotein receptors and cholesterol homeostasis
Robert W. Mahley;Thomas L. Innerarity.
Biochimica et Biophysica Acta (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: